(MDT:New York Consolidated)
Transactions by MEDTRONIC PLC (MDT) in the last 6 months
Medtronic plc (NYSE:MDT) acquired Sophono, Inc. on March 26, 2015. The transaction enables Medtronic's Ear Nose and Throat business to continue its focus on novel therapies and innovative technology solutions and supports Medtronic's therapy innovation strategy. Medtronic will include revenue from the Sophono product line as part of the Surgical Technologies division within the Restorative Therapies Group segment. The transaction is expected to meet Medtronic's long-term ...
Colorado Institute for Drug, Device & Diagnostic Development
Wexford Capital LLC
Wexford Capital, LLC, Private Equity Arm
Semma Therapeutics announced that it has received $44 million in its series A equity round of funding led by new investor, MPM Capital on March 24, 2015. The transaction included participation from new investors, Arch Venture Partners, L.P., Fidelity Biosciences, and Medtronic plc. As a part of the transaction, Robert Millman, Todd Foley, and Jim Scopa of MPM Capital, Steven Knight of Fidelity Biosciences joined the company’s board of directors and Stephen Oesterle of ...
Glooko, Inc. announced that it has received $16.5 million in its series B round of funding co-led by new investor, Canaan Partners and Medtronic plc on March 17, 2015. The transaction included participation from existing investors, Samsung Venture Investment Corporation and The Social+Capital Partnership. The company has raised $27.5 million in funding till date. As part of the round, Wende Huttonof Canaan Partners joined the company's board of directors.
Samsung Venture Investment Corporation
The Social+Capital Partnership
|3M Co||$162.52 USD||-2.43|
|Abbott Laboratories||$45.89 USD||-0.44|
|Astellas Pharma Inc||¥1,932 JPY||+14.50|
|Baxter International Inc||$67.54 USD||-0.96|
|View Industry Companies|